<SEC-DOCUMENT>0001193125-18-185016.txt : 20180606
<SEC-HEADER>0001193125-18-185016.hdr.sgml : 20180606
<ACCEPTANCE-DATETIME>20180606084636
ACCESSION NUMBER:		0001193125-18-185016
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20180606
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180606
DATE AS OF CHANGE:		20180606

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		18882997

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d598957d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT PURSUANT TO SECTION 13 OR 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): June&nbsp;6, 2018 </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g598957g0605175819676.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>CVS HEALTH CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Delaware
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction of Incorporation) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">001-01011</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">05-0494040</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Commission File Number)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(IRS Employer Identification No.)</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>One CVS Drive</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Woonsocket, Rhode Island</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>02895</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of Principal Executive Offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (401) <FONT STYLE="white-space:nowrap">765-1500</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter).
&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Emerging growth company&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) and (e)&nbsp;On June&nbsp;6, 2018, CVS Health Corporation (&#147;<U>CVS Health</U>&#148;) announced that David M. Denton, CVS Health&#146;s Executive Vice
President and Chief Financial Officer, will be leaving CVS Health at the close of the previously announced acquisition of Aetna Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with
Mr.&nbsp;Denton&#146;s departure, CVS Health has agreed to provide him 24 months of continued base salary as severance following his last day of employment, as well as subsidized benefits continuation for those 24 months (the &#147;<U>Severance
Period</U>&#148;). He will receive a <FONT STYLE="white-space:nowrap">pro-rated</FONT> bonus for calendar year 2018 based on his actual time worked.&nbsp;Mr.&nbsp;Denton&#146;s stock options and restricted stock unit awards (other than his retention
restricted stock unit award, which will fully vest on his last day of employment and will be settled in accordance with its terms) will continue to vest through the end of the Severance Period. His outstanding performance stock unit awards and LTIP
awards will vest on a <FONT STYLE="white-space:nowrap">pro-rated</FONT> basis through his last day of employment, assuming target performance levels, and they will be settled in accordance with their existing terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to receive the foregoing payments and benefits, Mr.&nbsp;Denton must remain employed with CVS Health as Chief Financial Officer through the earlier
of the closing of the previously announced acquisition of Aetna or December&nbsp;31, 2018. Mr.&nbsp;Denton will be subject to an 18 month <FONT STYLE="white-space:nowrap">non-compete</FONT> and
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants, and the payments will be conditioned upon the provision of a release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction
remains subject to regulatory approvals and other customary closing conditions and is still expected to close in the second half of 2018. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Events. </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;6, 2018, CVS Health issued a press release announcing the proposed senior
management team at CVS Health that is expected to be in place upon the closing of its previously announced acquisition of Aetna, Inc. Compensation arrangements for new members of the proposed senior management team have not yet been determined and
will be finalized at the time of appointment, which is expected to be at the time of the closing of the acquisition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the press release is filed
as Exhibit 99.1 hereto and incorporated by reference herein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Offer or Solicitation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication is for informational purposes only and not intended to and does not constitute an offer to subscribe for, buy or sell, the solicitation of
an offer to subscribe for, buy or sell or an invitation to subscribe for, buy or sell any securities or the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed transaction or otherwise, nor shall
there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section&nbsp;10 of the Securities Act of
1933, as amended, and otherwise in accordance with applicable law. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Information and Where to Find It </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the proposed transaction between CVS Health Corporation (&#147;CVS Health&#148;) and Aetna Inc. (&#147;Aetna&#148;), CVS Health filed a
registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> with the Securities and Exchange Commission (the &#147;SEC&#148;), which includes a joint proxy statement of CVS Health and Aetna that also constitutes a prospectus of CVS
Health. The registration statement was declared effective by the SEC on February&nbsp;9, 2018, and CVS Health and Aetna commenced mailing the definitive joint proxy statement/prospectus to stockholders of CVS Health and shareholders of Aetna on or
about February&nbsp;12, 2018 and the special meeting of the stockholders of CVS Health and the shareholders of Aetna was held on March&nbsp;13, 2018. INVESTORS AND SECURITY HOLDERS OF CVS HEALTH AND AETNA ARE URGED TO READ THE DEFINITIVE JOINT PROXY
STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders may obtain free copies of the registration
statement and the definitive joint proxy statement/prospectus and other documents filed with the SEC by CVS Health or Aetna through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by CVS Health are
available free of charge within the Investors section of CVS Health&#146;s Web site at http://www.cvshealth.com/investors or by contacting CVS Health&#146;s Investor Relations Department at <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">800-201-0938.</FONT></FONT> Copies of the documents filed with the SEC by Aetna are available free of charge on Aetna&#146;s internet website at http://www.Aetna.com or by contacting Aetna&#146;s Investor Relations
Department at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">860-273-0896.</FONT></FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement Regarding
Forward-Looking&nbsp;Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Securities Litigation Reform Act of 1995 (the &#147;Reform Act&#148;) provides a safe harbor for
forward-looking statements made by or on behalf of CVS Health or Aetna. This communication may contain forward-looking statements within the meaning of the Reform Act. You can generally identify forward-looking statements by the use of
forward-looking terminology such as &#147;anticipate,&#148; &#147;believe,&#148; &#147;can,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;evaluate,&#148; &#147;expect,&#148; &#147;explore,&#148; &#147;forecast,&#148;
&#147;guidance,&#148; &#147;intend,&#148; &#147;likely,&#148; &#147;may,&#148; &#147;might,&#148; &#147;outlook,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;probable,&#148; &#147;project,&#148; &#147;seek,&#148;
&#147;should,&#148; &#147;view,&#148; or &#147;will,&#148; or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are only predictions and involve known and unknown risks and uncertainties,
many of which are beyond CVS Health&#146;s and Aetna&#146;s control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cautioned not to place undue reliance on any forward-looking statements.
These forward-looking statements are and will be based upon management&#146;s then-current views and assumptions regarding future events and are applicable only as of the dates of such statements. Neither CVS Health nor Aetna assumes any duty to
update or revise forward-looking statements, whether as a result of new information, future events or otherwise, as of any future date. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP><B>99.1</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d598957dex991.htm">Press Release, dated June&nbsp;6, 2018, of CVS Health Corporation. </A></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CVS HEALTH CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Colleen M. McIntosh</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Colleen M. McIntosh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Corporate Secretary and Assistant General Counsel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Dated: June&nbsp;6, 2018</TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d598957dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g598957g0606040756046.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS Health Announces Management Team for Combined Company Following </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Close of Aetna Acquisition Transaction </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Executives of both companies appointed to drive forward future vision </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Transaction expected to close in second half of 2018, subject to required regulatory approvals </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Woonsocket, RI (June 6, 2018) &#150; </B>CVS Health (NYSE: CVS) today announced the management team that following the close of the Aetna (NYSE: AET)
acquisition will lead the combined company into the future. Aetna will operate as a stand-alone business unit within the CVS Health enterprise following the close and will be led by members of their current management team. In addition, members of
both the Aetna and CVS Health management teams will play significant roles in the newly combined company. The transaction is expected to close in the second half of 2018, subject to required regulatory approvals. Until the close of the transaction,
CVS Health and Aetna will continue to operate as two separate companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We&#146;re very excited to be taking this milestone step in the journey to
combine our two great companies,&#148; said CVS Health President and Chief Executive Officer Larry J. Merlo. &#147;The talent of both organizations is reflected in the management team that we are naming today and that will report to me as of the
close of the transaction. I look forward to working alongside this outstanding group of individuals as we take on the task of transforming the way health care is delivered in America &#150; engaging consumers with the care they need, when and where
they need it, and making the patient and caregiver experience simpler and more affordable.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management positions announced today include business
unit and shared services leaders as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business Unit Leadership </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Jon Roberts</B> will continue to serve as Executive Vice President and Chief Operating Officer for CVS Health with operational oversight for CVS Pharmacy,
CVS Caremark and Omnicare. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Karen S. Lynch,</B> currently President of Aetna, will serve as Executive Vice President of CVS Health and President for
the Aetna business unit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fran S. Soistman</B> will continue to serve in his current position of Executive Vice President and Head of Government
Services for Aetna, leading the Medicare, Medicaid and Federal Plans businesses reporting to Lynch. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Alan M. Lotvin, M.D., </B>currently Executive Vice
President of Specialty Pharmacy for CVS Caremark, has been named Executive Vice President, Transformation, with oversight of the portfolio of business transformation initiatives for the combined company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Richard di Benedetto</B> will continue to serve in his current position of President of Aetna International. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Shared Service Leadership </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Shawn M. Guertin,</B> currently Executive Vice President, Chief Financial Officer and Chief Enterprise Risk Officer for Aetna, will assume the position of
Executive Vice President and Chief Financial Officer for CVS Health. In this role, Guertin will have oversight of Investor Relations, Financial Planning and Analysis for the lines of business, Tax and Treasury functions, and Accounting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thomas M. Moriarty</B> will continue to serve as Executive Vice President, Chief Policy and External Affairs Officer and General Counsel for CVS Health.
Moriarty&#146;s responsibilities include Government Affairs, Corporate Communications and Legal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Troyen A. Brennan, M.D., M.P.H.</B> will continue to
serve as Executive Vice President and Chief Medical Officer for CVS Health. Brennan provides oversight for clinical and medical affairs and health care services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rick M. Jelinek,</B> currently Executive Vice President, Head of Enterprise Strategy for Aetna, will be appointed Executive Vice President, CVS Health. In
this role following the close of the transaction, Jelinek will continue to <FONT STYLE="white-space:nowrap">co-lead</FONT> the combined company&#146;s integration efforts alongside <B>Josh Flum, </B>Executive Vice President of Enterprise Strategy
and Corporate Development for CVS Health. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Lisa Bisaccia</B> will continue to serve as Executive Vice President and Chief Human Resources Officer. In
addition to leading the Human Resources organization, Bisaccia will provide strategic oversight for the combined company&#146;s corporate social responsibility and philanthropic activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Also as part of the transition of the organizations, several executives from both CVS Health and Aetna will be departing. <B>David Denton, </B>who currently
serves as CVS Health&#146;s Chief Financial Officer has elected to depart the company at the close. Similarly, Aetna executives <B>Steven B. Kelmar,</B> Executive Vice President, Corporate Affairs; <B>Thomas J. Sabatino, Jr., </B>Executive Vice
President and General Counsel; and <B>Thomas W. Weidenkopf, </B>Executive Vice President and Chief Human Resources Officer, will remain in their roles until the close of the transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To assist with the transition following the close, Aetna executives <B>Harold L. Paz, M.D., M.S., </B>Executive Vice President and Chief Medical Officer, and
<B>Meg McCarthy,</B> Executive Vice President, Operations and Technology, will remain with the organization for a period of time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I would like to
extend my thanks and gratitude to all of these individuals who have so ably served both organizations during a time when the health care marketplace has been changing dynamically,&#148; said Merlo. &#147;I am especially grateful to Dave Denton for
his leadership and contributions during nearly 20 years serving CVS Health &#150; from the company it was to the company it has become. Dave has been a driving force behind the growth of CVS Health and I wish him all the best.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed, upon the closing of the transaction, three of Aetna&#146;s directors, including Aetna&#146;s Chairman and CEO <B>Mark T. Bertolini,
</B>will be added to the CVS Health Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CVS Health </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,800 retail locations, more than 1,100 <FONT
STYLE="white-space:nowrap">walk-in</FONT> medical clinics, a leading pharmacy benefits manager with approximately 94&nbsp;million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding
specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases
access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at&nbsp;https://www.cvshealth.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact:</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mike McGuire </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(401)
<FONT STYLE="white-space:nowrap">770-4050</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>michael.mcguire@cvshealth.com</U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Carolyn Castel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Carolyn.Castel@CVSHealth.com </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">401-770-5717</FONT></FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Offer or Solicitation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication is for informational purposes only and not intended to and does not constitute an offer to subscribe for, buy or sell, the solicitation of
an offer to subscribe for, buy or sell or an invitation to subscribe for, buy or sell any securities or the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed transaction or otherwise, nor shall
there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section&nbsp;10 of the Securities Act of
1933, as amended, and otherwise in accordance with applicable law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Information and Where to Find It </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the proposed transaction between CVS Health Corporation (&#147;CVS Health&#148;) and Aetna Inc. (&#147;Aetna&#148;), CVS Health filed a
registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> with the Securities and Exchange Commission (the &#147;SEC&#148;), which includes a joint proxy statement of CVS Health and Aetna that also constitutes a prospectus of CVS
Health. The registration statement was declared effective by the SEC on February&nbsp;9, 2018, and CVS Health and Aetna commenced mailing the definitive joint proxy statement/prospectus to stockholders of CVS Health and shareholders of Aetna on or
about February&nbsp;12, 2018, and the special meeting of the stockholders of CVS Health and the shareholders of Aetna was held on March&nbsp;13, 2018. INVESTORS AND SECURITY HOLDERS OF CVS HEALTH AND AETNA ARE URGED TO READ THE DEFINITIVE JOINT
PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders may obtain free copies of the registration statement and the
definitive joint proxy statement/prospectus and other documents filed with the SEC by CVS Health or Aetna through the website maintained by the SEC at <U>http://www.sec.gov</U>. Copies of the documents filed with the SEC by CVS Health are available
free of charge within the Investors section of CVS Health&#146;s Web site at http://www.cvshealth.com/investors or by contacting CVS Health&#146;s Investor Relations Department at <FONT STYLE="white-space:nowrap">800-201-0938.</FONT> Copies of the
documents filed with the SEC by Aetna are available free of charge on Aetna&#146;s internet website at http://www.Aetna.com or by contacting Aetna&#146;s Investor Relations Department at <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">860-273-0896.</FONT></FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement Regarding Forward-Looking&nbsp;Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Securities Litigation Reform Act of 1995 (the &#147;Reform Act&#148;) provides a safe harbor for forward-looking statements made by or on behalf of
CVS Health or Aetna. This communication may contain forward-looking statements within the meaning of the Reform Act. You can generally identify forward-looking statements by the use of forward-looking terminology such as &#147;anticipate,&#148;
&#147;believe,&#148; &#147;can,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;evaluate,&#148; &#147;expect,&#148; &#147;explore,&#148; &#147;forecast,&#148; &#147;guidance,&#148; &#147;intend,&#148; &#147;likely,&#148;
&#147;may,&#148; &#147;might,&#148; &#147;outlook,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;probable,&#148; &#147;project,&#148; &#147;seek,&#148; &#147;should,&#148; &#147;view,&#148; or &#147;will,&#148; or the
negative thereof or other variations thereon or comparable terminology. These forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond CVS Health&#146;s and Aetna&#146;s control.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Statements in this communication that are forward-looking, including projections as to the closing date for the
pending acquisition of Aetna (the &#147;transaction&#148;), the extent of, and the time necessary to obtain, the regulatory approvals required for the transaction, the anticipated benefits of the transaction, the impact of the transaction on CVS
Health&#146;s and Aetna&#146;s businesses, the expected terms and scope of the expected financing for the transaction, the ownership percentages of CVS Health&#146;s common stock of CVS Health stockholders and Aetna shareholders at closing, the
aggregate amount of indebtedness of CVS Health following the closing of the transaction, CVS Health&#146;s expectations regarding debt repayment and its debt to capital ratio following the closing of the transaction, CVS Health&#146;s and
Aetna&#146;s respective share repurchase programs and ability and intent to declare future dividend payments, the number of prescriptions used by people served by the combined companies&#146; pharmacy benefit business, the synergies from the
transaction, and CVS Health&#146;s, Aetna&#146;s and/or the combined company&#146;s future operating results, are based on CVS Health&#146;s and Aetna&#146;s managements&#146; estimates, assumptions and projections, and are subject to significant
uncertainties and other factors, many of which are beyond their control. In particular, projected financial information for the combined businesses of CVS Health and Aetna is based on estimates, assumptions and projections and has not been prepared
in conformance with the applicable accounting requirements of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> relating to pro forma financial information, and the required pro forma adjustments have not been applied and are not reflected
therein. None of this information should be considered in isolation from, or as a substitute for, the historical financial statements of CVS Health and Aetna. Important risk factors related to the transaction could cause actual future results and
other future events to differ materially from those currently estimated by management, including, but not limited to: the timing to consummate the proposed transaction; the risk that a regulatory approval that may be required for the proposed
transaction is delayed, is not obtained or is obtained subject to conditions that are not anticipated; the risk that a condition to the closing of the proposed transaction may not be satisfied; the outcome of litigation related to the transaction;
the ability to achieve the synergies and value creation contemplated; CVS Health&#146;s ability to promptly and effectively integrate Aetna&#146;s businesses; and the diversion of and attention of management of both CVS Health and Aetna on
transaction-related issues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, this communication may contain forward-looking statements regarding CVS Health&#146;s or Aetna&#146;s respective
businesses, financial condition and results of operations. These forward-looking statements also involve risks, uncertainties and assumptions, some of which may not be presently known to CVS Health or Aetna or that they currently believe to be
immaterial also may cause CVS Health&#146;s or Aetna&#146;s actual results to differ materially from those expressed in the forward-looking statements, adversely impact their respective businesses, CVS Health&#146;s ability to complete the
transaction and/or CVS Health&#146;s ability to realize the expected benefits from the transaction. Should any risks and uncertainties develop into actual events, these developments could have a material adverse effect on the transaction and/or CVS
Health or Aetna, CVS Health&#146;s ability to successfully complete the transaction and/or realize the expected benefits from the transaction. Additional information concerning these risks, uncertainties and assumptions can be found in CVS
Health&#146;s and Aetna&#146;s respective filings with the SEC, including the risk factors discussed in &#147;Item 1.A. Risk Factors&#148; in CVS Health&#146;s and Aetna&#146;s most recent Annual Reports on Form
<FONT STYLE="white-space:nowrap">10-K,</FONT> as updated by their Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and future filings with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements are and will be based upon
management&#146;s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. Neither CVS Health nor Aetna assumes any duty to update or revise forward-looking
statements, whether as a result of new information, future events or otherwise, as of any future date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g598957g0605175819676.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g598957g0605175819676.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  P )D# 2(  A$! Q$!_\0
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M>&1&>&82NEVN0&5@>!QDUUWV23XB>--8M;^ZNH=$TD11+:0RF,RR.@<LQ'/
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L@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g598957g0606040756046.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g598957g0606040756046.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !1 0$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *0D*,D@ =S39)$AB:21@J*,L3V%>/^,O&TVK3
MM9V$C1V:'!93@R'_  J)U%!79VX' U,9/EAHNK['L2LKC*L&'J#FAF51EB !
MW)KP_P *^,+K0;L+,[S6;GYT)R1[BI?%OC2YUVY\JU=X;)#\J@X+>YK/V\>6
MYZ']@U_;^SO[O?\ KJ>UJP894@@]P:6O%_!_C2?1;@6UX[RV3GG)R4]Q7K-Y
MJ]K9Z.^IM(&MU3>I!^]Z5<*BDKG%C,NJX6JH/6^S[EXD 9) 'O3%GA9MJRQD
M^@85X7K?BW5=<NF)GDCA)PD,9P!_C5*6SUFRA%U+%=Q1GD2'(K-XCLCTH</R
MY5[2HDWT/H6C(]:\8T+Q;?3V\NCWMR[QSH5BE)^9&[<U@QZQJ=K>J7O)\Q2?
M,"Y[&AXA;V(CD%5RE%R2:_$^A:3(]:SY-2C30&U+<-H@\S/X5X8NJ:I>WX1+
MRXW328 #GC)JYU5"QR8'+)XM2?-R\I]"9XS4?VB#=M\Z/=Z;A7B6O^*=0G<:
M?!<R1VMN/+^5N7(ZDGZU2.B:^NGC4O(N?LY&[S-QZ>M0Z^NB.R&1>ZI5:BC?
M8]^I,CUKQWP=XPO['4X;2[F>:TE8(0YR5)Z$&G?'#1KBWT27Q-:ZQ?6\L7EQ
M"WB?:AR>OUK6$U-71YF.P-3!U.2>M]F>PYS1D#O7%?#/P\^C>&XKJ34[N^>^
MC29OM#9V''0>U9_Q<T&6^\-7&L0ZK>6<NG0,ZQP/M60Y[U9Q'HN0>]%>6?!?
M0YD\.P>(;C5[VZEOH<-#,^Y$P>HKU.@ HHHH **** $R/6EKQ3XZ:7=:?:Q^
M)+36+Z&1I(X#;QR%8\>O'>O1]0U\>'? *ZU-$UQ]GLXY&0'!;Y1WH Z2DR/6
MN?TK4$\;>"HKQ/-LUU" XVM\T>>.#ZUYG\,8KS2OBSXCT.74[N]M[.(*AN')
M)YZXH ]MHHHH **** "BBB@"GJMD=1TJYLP^PS1E0WI7@&J:7=:1?26EW&4D
M0_@1ZBOHNL/Q+X:M?$5B8Y $N%'[J4#D'_"L:M/G5UN>QE.9?5)N$_A?X'@=
M%7=5TJZT>^>TNXRCJ>#V8>HING:=<ZI>QVEI&7E<XP.WN:XK.]C[7VD.3GOI
MW$T_3[G5+V.TM(S)*YP .WO7HOC2VET;P)IVFF3<0X5R.^.:ZGPMX6MO#ED
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JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
